Irina Valeryevna Gilevich

Irina Valeryevna Gilevich

Auto-generated profile, based on publicly available information

Irina Valeryevna Gilevich

Kuban State Medical University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Burns
Verified
Journal Article
Closed access
SBSergey B. Bogdanov
Sergey B. Bogdanov
IGIrina V. Gilevich
Irina V. Gilevich
KMKarina I. Melkonyan
Karina I. Melkonyan
ASAlexander S. Sotnichenko
Alexander S. Sotnichenko
SASergey N. Alekseenko
Sergey N. Alekseenko
VPVladimir A. Porhanov
Vladimir A. Porhanov

28 December 2017 in Pediatric Traumatology, Orthopaedics and Reconstructive Surgery
Verified
Journal Article
Open access
PDF file
VPVladimir A. Porhanov
Vladimir A. Porhanov
SBSergey B. Bogdanov
Sergey B. Bogdanov
IGIrina V. Gilevich
Irina V. Gilevich
TFTatyana V. Fedorenko
Tatyana V. Fedorenko
EKElena A. Kolomiyceva
Elena A. Kolomiyceva
YBYulia A. Bogdanova
Yulia A. Bogdanova
In addition to the physical injury, deep burns of the face also can cause psychological injury. The purpose of this study was to develop new technical methods for improving engraftment of full-thickness autografts. Since 2017, autologous fibroblasts have been used for skin facioplasty of one full thickness autograft in Scientific Research Institue, Reginal Clinical Hospital No 1. Isolation of fibroblasts was performed by using an enzymatic method and a skin sample with an area of 10 cm2. Cultivation of autologous fibroblasts was performed for 22 days according to a standard procedure. The prepared culture of autologous fibroblasts was used together with a full-layer autologous transplant to close the wound on the face. We found that autologous fibroblasts provided faster adaptation of the autograft. There were no signs of fibrous tissue over the long term. We concluded that fibroblasts promoted rapid engraftment and adaptation of the full-thickness autograft. Improvement of facial plastic surgery methods can help achieve maximum cosmetic treatment results.

10 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SKSofia Kruchinova
Sofia Kruchinova
MGMilana Gendugova
Milana Gendugova
Alim NamitokovAlim Namitokov
Alim Namitokov
MSMaria Sokolskaya
Maria Sokolskaya
IGIrina Gilevich
Irina Gilevich
Vladimir ShvartzVladimir Shvartz
Vladimir Shvartz
Background: Despite the vast evidence of the beneficial effect of vagus nerve stimulation on the course of myocardial infarction confirmed in studies using animal models, the introduction of this method into actual clinical practice remains uncommon. Objective: The objective of our study was to evaluate the effect of transcutaneous vagus nerve stimulation (tVNS) on in-hospital and long-term outcomes for patients with ST-elevation myocardial infarction. Materials and Methods: A blind, randomized, placebo-controlled clinical trial was conducted. The participants were randomly split into two groups. The Active tVNS group was subjected to stimulation of the tragus containing the auricular branch of the vagus nerve. The Sham tVNS group underwent stimulation of the lobule. Stimulation was performed immediately on admission before the start of the percutaneous coronary intervention (PCI). Then, tVNS continued throughout the entire PCI procedure and 30 min after its completion. The primary endpoints were hospital mortality and 12-month mortality. The secondary endpoints were in-hospital and remote non-lethal cardiovascular events. The combined endpoint consisted of major adverse cardiovascular events (MACEs)—recurrent myocardial infarction, stroke/TIA, and overall mortality. Results: A total of 110 patients were randomized into the Active tVNS group (n = 55) and the Sham tVNS group (n = 55). The incidences of hospital mortality, cardiogenic shock, and AV block 3 were statistically less common in the Active tVNS group than in the Sham tVNS group (p = 0.024*, p = 0.044*, and p = 0.013*, respectively). In the long-term period, no statistical differences were found in the studied outcomes obtained following the construction of Kaplan–Meyer survival curves. When comparing groups by total mortality, taking into account hospital mortality, we observed a tendency for the survival curves to diverge (Logrank test, p = 0.066). Statistical significance was revealed by the composite endpoint, taking into account hospital events (Logrank test, p = 0.0016*). Conclusions: tVNS significantly reduced hospital mortality (p = 0.024*), the level of markers of myocardial damage, and the frequency of severe cardiac arrhythmias in patients with acute myocardial infarction. In the long term, the prognostic value of tVNS was revealed by the composite endpoint major adverse cardiovascular events. Further studies with an expanded sample are needed for a more detailed verification of the data obtained to confirm the effectiveness of tVNS and allow an in-depth analysis of the safety and feasibility of its use in routine clinical practice. This clinical trial is registered with ClinicalTrials database under a unique identifier: NCT05992259.

26 July 2017 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
IGI. V. Gilevich
I. V. Gilevich
IPI. S. Polyakov
I. S. Polyakov
VPV. A. Porkhanov
V. A. Porkhanov
VCVladimir Chehonin
Vladimir Chehonin

9 June 2023 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
VFV. I. Fetisova
V. I. Fetisova
Alim NamitokovAlim Namitokov
Alim Namitokov
IGI. V. Gilevich
I. V. Gilevich
EKE. D. Kosmacheva
E. D. Kosmacheva
Many prognostic tools have been developed over the past decades, however, the identification of biomarkers that can predict the risk of acute coronary disease and its associated complications, especially heart failure, remains a promising direction, the study of which will provide understanding of the pathophysiology of this disease and identify new targets for therapy. One such potential biomarker is soluble suppression of tumorigenicity 2, which is able not only to predict left ventricular remodeling and poor clinical outcome among patients with acute coronary syndrome, but also to complement other well-established cardiac biomarkers such as natriuretic peptides and cardiac troponins. At the same time, if a number of separate but often converging pathways are involved in the pathogenesis of acute coronary disease, then multimarker approaches with various combinations of new cardiac biomarkers and their continuous assessment are likely to improve the prediction of cardiac risk and long-term outcomes.

19 December 2023 in Russian Journal of Spine Surgery (Khirurgiya Pozvonochnika)
Verified
Journal Article
Open access
PDF file
ИКИрина Анатольевна Кирилова
Ирина Анатольевна Кирилова
DADiana Ya. Aleynik
Diana Ya. Aleynik
ИБИгорь Вадимович Басанкин
Игорь Вадимович Басанкин
SBSvetlana Bozhkova
Svetlana Bozhkova
НБНаталья Валерьевна Боровкова
Наталья Валерьевна Боровкова
КВКонстантин Александрович Воробьев
Константин Александрович Воробьев
An interdisciplinary consensus of experts has been formed in the area of medical activity such as tissue banking. An analysis and attempt was made to systematize some of the terms and definitions used by tissue bank specialists in the process of their work and presented in the Federal laws and orders of the Ministry of Health of the Russian Federation regulating medical activities in the field of tissue donation and their clinical use.